Submission Details
| 510(k) Number | K221705 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 13, 2022 |
| Decision Date | February 28, 2023 |
| Days to Decision | 260 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K221705 is an FDA 510(k) clearance for the U2 Total Knee System-PF+, a Prosthesis, Knee, Patello/femorotibial, Semi-constrained, Uncemented, Porous, Coated, Polymer/metal/polymer (Class II — Special Controls, product code MBH), submitted by United Orthopedic Corporation (Hsinchu City, TW). The FDA issued a Cleared decision on February 28, 2023, 260 days after receiving the submission on June 13, 2022. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3565.
| 510(k) Number | K221705 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 13, 2022 |
| Decision Date | February 28, 2023 |
| Days to Decision | 260 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | MBH — Prosthesis, Knee, Patello/femorotibial, Semi-constrained, Uncemented, Porous, Coated, Polymer/metal/polymer |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3565 |